402 research outputs found

    Concerning the existence of Einstein and Ricci soliton metrics on solvable Lie groups

    Full text link
    In this work we investigate solvable and nilpotent Lie groups with special metrics. The metrics of interest are left-invariant Einstein and algebraic Ricci soliton metrics. Our main result shows that the existence of a such a metric is intrinsic to the underlying Lie algebra. More precisely, we show how one may determine the existence of such a metric by analyzing algebraic properties of the Lie algebra in question and infinitesimal deformations of any initial metric. Our second main result concerns the isometry groups of such distinguished metrics. Among the completely solvable unimodular Lie groups (this includes nilpotent groups), if the Lie group admits such a metric, we show that the isometry group of this special metric is maximal among all isometry groups of left-invariant metrics. We finish with a similar result for locally left-invariant metrics on compact nilmanifolds.Comment: 28 page

    New Spirometry Indices for Detecting Mild Airflow Obstruction.

    Get PDF
    The diagnosis of chronic obstructive pulmonary disease (COPD) relies on demonstration of airflow obstruction. Traditional spirometric indices miss a number of subjects with respiratory symptoms or structural lung disease on imaging. We hypothesized that utilizing all data points on the expiratory spirometry curves to assess their shape will improve detection of mild airflow obstruction and structural lung disease. We analyzed spirometry data of 8307 participants enrolled in the COPDGene study, and derived metrics of airflow obstruction based on the shape on the volume-time (Parameter D), and flow-volume curves (Transition Point and Transition Distance). We tested associations of these parameters with CT measures of lung disease, respiratory morbidity, and mortality using regression analyses. There were significant correlations between FEV1/FVC with Parameter D (r = -0.83; p < 0.001), Transition Point (r = 0.69; p < 0.001), and Transition Distance (r = 0.50; p < 0.001). All metrics had significant associations with emphysema, small airway disease, dyspnea, and respiratory-quality of life (p < 0.001). The highest quartile for Parameter D was independently associated with all-cause mortality (adjusted HR 3.22,95% CI 2.42-4.27; p < 0.001) but a substantial number of participants in the highest quartile were categorized as GOLD 0 and 1 by traditional criteria (1.8% and 33.7%). Parameter D identified an additional 9.5% of participants with mild or non-recognized disease as abnormal with greater burden of structural lung disease compared with controls. The data points on the flow-volume and volume-time curves can be used to derive indices of airflow obstruction that identify additional subjects with disease who are deemed to be normal by traditional criteria

    The Finite Temperature SU(2) Savvidy Model with a Non-trivial Polyakov Loop

    Full text link
    We calculate the complete one-loop effective potential for SU(2) gauge bosons at temperature T as a function of two variables: phi, the angle associated with a non-trivial Polyakov loop, and H, a constant background chromomagnetic field. Using techniques broadly applicable to finite temperature field theories, we develop both low and high temperature expansions. At low temperatures, the real part of the effective potential V_R indicates a rich phase structure, with a discontinuous alternation between confined (phi=pi) and deconfined phases (phi=0). The background field H moves slowly upward from its zero-temperature value as T increases, in such a way that sqrt(gH)/(pi T) is approximately an integer. Beyond a certain temperature on the order of sqrt(gH), the deconfined phase is always preferred. At high temperatures, where asymptotic freedom applies, the deconfined phase phi=0 is always preferred, and sqrt(gH) is of order g^2(T)T. The imaginary part of the effective potential is non-zero at the global minimum of V_R for all temperatures. A non-perturbative magnetic screening mass of the form M_m = cg^2(T)T with a sufficiently large coefficient c removes this instability at high temperature, leading to a stable high-temperature phase with phi=0 and H=0, characteristic of a weakly-interacting gas of gauge particles. The value of M_m obtained is comparable with lattice estimates.Comment: 28 pages, 5 eps figures; RevTeX 3 with graphic

    Lymphovascular space invasion and lack of downstaging after neoadjuvant chemotherapy are strong predictors of adverse outcome in young women with locally advanced breast cancer

    Get PDF
    Younger age diagnosis of breast cancer is a predictor of adverse outcome. Here, we evaluate prognostic factors in young women with locally advanced breast cancer (LABC). We present a retrospective review of 104 patients younger than 40 years with LABC treated with surgery, radiotherapy (RT), and chemotherapy from 2003 to 2014. Patient‐, tumor‐, and treatment‐related factors important for overall survival (OS), local/regional recurrence (LRR), distant metastasis (DM), and recurrence‐free survival (RFS) were evaluated. Mean age at diagnosis was 34 years (23–39 years) with a median follow‐up of 47 months (8–138 months). Breast‐conserving surgery was performed in 27%. Axillary lymph node dissection was performed in 85%. Sixty percent of patients received neoadjuvant chemotherapy with 19% achieving pathologic complete response (pCR), and 61% downstaged. Lymph node positivity was present in 91% and lymphovascular space invasion (LVSI) in 35%. Thirty‐two percent of patients had triple negative tumors (TN, ER‐/PR‐/HER2 nonamplified). Four‐year OS and RFS was 84% and 71%, respectively. Factors associated with worse OS on multivariate analysis include TN status, LVSI, and number of positive lymph nodes. LVSI was also associated with DM and LRR, as well as worse RFS. Downstaging was associated with improved 4 year RFS in patients receiving neoadjuvant chemotherapy (74% vs. 38%, P = 0.002). With high risks of recurrence and inferior OS compared to older women, breast cancer in young women can be difficult to treat. Among additional factors, presence of LVSI and lack of downstaging portends a particularly worse prognosis

    Anti-oxidant inhibition of hyaluronan fragment-induced inflammatory gene expression

    Get PDF
    <p>Abstract</p> <p>Background</p> <p>The balance between reactive oxygen species (ROS) and endogenous anti-oxidants is important in maintaining healthy tissues. Excessive ROS states occur in diseases such as ARDS and Idiopathic Pulmonary Fibrosis. Redox imbalance breaks down the extracellular matrix component hyaluronan (HA) into fragments that activate innate immune responses and perpetuate tissue injury. HA fragments, via a TLR and NF-κB pathway, induce inflammatory gene expression in macrophages and epithelial cells. NAC and DMSO are potent anti-oxidants which may help balance excess ROS states.</p> <p>Methods</p> <p>We evaluated the effect of H<sub>2</sub>O<sub>2</sub>, NAC and DMSO on HA fragment induced inflammatory gene expression in alveolar macrophages and epithelial cells.</p> <p>Results</p> <p>NAC and DMSO inhibit HA fragment-induced expression of TNF-α and KC protein in alveolar and peritoneal macrophages. NAC and DMSO also show a dose dependent inhibition of IP-10 protein expression, but not IL-8 protein, in alveolar epithelial cells. In addition, H<sub>2</sub>O<sub>2 </sub>synergizes with HA fragments to induce inflammatory genes, which are inhibited by NAC. Mechanistically, NAC and DMSO inhibit HA induced gene expression by inhibiting NF-κB activation, but NAC had no influence on HA-fragment-AP-1 mediated gene expression.</p> <p>Conclusion</p> <p>ROS play a central role in a pathophysiologic "vicious cycle" of inflammation: tissue injury generates ROS, which fragment the extracellular matrix HA, which in turn synergize with ROS to activate the innate immune system and further promote ROS, HA fragment generation, inflammation, tissue injury and ultimately fibrosis. The anti-oxidants NAC and DMSO, by inhibiting the HA induced inflammatory gene expression, may help re-balance excessive ROS induced inflammation.</p
    corecore